Background: Mitral valve repair is well established as the preferred treatment modality for the majority of patients with degenerative mitral valve disease requiring intervention. Valve repair offers a distinct event-free survival advantage compared with replacement with either a bioprosthetic or mechanical valve. At present, there are little data available on the management and outcome of mitral valve repair in South Africa. The aim of this study is to describe and compare the indications, specifi c pathology and outcomes of patients accepted for mitral valve repair. Internationally published fi gures for peri-operative mortality are less than 2% for degenerative mitral regurgitation, with a freedom from mitral valve reoperation of 94% at 10 years. Methods: All patients referred for mitral valve repair at Tygerberg Hospital, Cape Town, South Africa, between 1 December 2010 and 30 June 2015, were retrospectively included. Demographic characteristics, cardiovascular risk factors, pre-operative (NYHA) functional class, the pre-and post-operative transthoracic and transoesophageal echocardiograms, immediate in hospital mortality and 6-month post-surgical mortality and functional class were analysed. Repair failure was defi ned as either intra-operative conversion to MVR or need for reoperation at 6 months. Results: A total of 147 patients were referred for mitral valve repair, of which 114 patients were accepted for mitral valve repair by the local heart team. In total, 106 of the 114 patients underwent surgical intervention, 6 defaulted their surgical dates, and 2 refused surgery. Of those accepted for surgery, 57.9% were males, 42.1% were females, with a mean age of 47.7 years in both groups combined, 44.7% had hypertension, 43.9% were smokers and 21.1% had concomitant IHD; 56.1% were pre-operative NYHA functional class III, 29.8% were class II, 7% class IV, and 7% were class I; 60.2% had a 6-month post-operative NYHA functional class I, 32.3% had class II, 5.4% class III, and 2.2% had class IV. Mitral valve prolapse (MVP) with fl ail segment due to chord rupture was the predominant etiology (29%); P2 was the most common segment involved (36%), followed by A2 (29.8%). For MVP, including patients with infective endocarditis, the mortality rate was 4.8% at 30 days and 6 months. The overall mortality rates for all patients accepted for mitral valve repair were 4.7% and 6.6% at 30 days and 6 months respectively. Freedom from reoperation was 98% at 6 months. There was a signifi cant association between bileafl et involvement and mitral valve repair failure (p=0.006). Chordal insertion with annuloplasty was the most common intervention used (45.5%). Conclusion: Mitral valve prolapse was the predominant etiology in patients referred for mitral valve repair. The mortality rate for mitral valve repair in the prolapse group was 4.8% at 6 months. Chordal insertion with annuloplasty was the most common intervention used. Bileafl et involvement was found to be an independent risk factor for repair failure. The mortality rate for all patients accepted for mitral valve repair was 6.6% at 6 months. SAHeart 2018;15:182-189 
INTRODUCTION
Degenerative mitral valve prolapse (MVP) as a clinical entity has only been recognised for some 50 years, since Barlow and colleagues proposed that mid to late systolic clicks and apical late systolic murmurs were of mitral valve origin. (1) In a study of the Framingham Offspring Study cohort, the prevalence of mitral valve prolapse was 2.5%, and it is now recognised as the most common cause of chronic mitral regurgitation with more than 150 million people affected worldwide. (2, 3) Echocardiographically, mitral valve prolapse is characterised by excessive leaflet motion, defined as displacement of any part of the mitral valve leaflet to ≥2mm above the mitral annular plane. (2) The natural history of mitral valve prolapse is extremely variable and is largely determined by the severity of mitral regurgitation (MR). (2) Although the majority of patients remain asymptomatic and may have a near normal life expectancy, approximately 5% -10% have progression to severe mitral regurgitation, which has a mortality rate approaching 6% -7%
per year. (4) (5) (6) Internationally published figures of peri-operative mortality for mitral valve repair is less than 2% for degenerative mitral regurgitation, and ranges from 5% -10% for functional (ischaemic) mitral regurgitation. 
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Degenerative MVP is considered as a spectrum rather than an entity, and it is responsible for the syndromes of mitral valve thickening with bileaflet prolapse (Barlow's syndrome),
MVP and flail leaflet. The pathology of these is mainly caused by 2 processes -myxomatous degeneration and fibroelastic deficiency. (8, 9) Myxomatous degeneration is typically seen in younger individuals and is recognised by thickening of the mitral leaflets (>5mm) on echocardiography, with associated prolapse of the mitral valve (usually bileaflet). Fibroelastic deficiency, on the other hand, is seen in elderly patients and is characterised on echocardiography by normal leaflet thickness with either prolapse or chordal rupture and flail segments. (8, 9) The management of severe MR has changed dramatically with the development of surgical mitral valve repair introduced by Alain Carpentier. (10) Mitral valve repair is now well established and is the standard of care for patients with mitral valve prolapse due to degenerative mitral valve disease. (11) Repair has a distinct advantage in terms of event-free survival compared with replacement with a bioprosthetic or mechanical valve. (12) Matching echocardiographic findings to the appropriate surgical skill level is required to consistently deliver a durable repair.
Different surgical techniques are used, including leaflet resection, plication, implantation of artificial chords, and leaflet reduction.
Most modern techniques incorporate restrictive annuloplasty
with an annuloplasty ring, as it supports the repair and improves the durability thereof. (2) The current practice at Tygerberg Hospital (TBH), Cape Town, South Africa, for the management of patients with mitral valve prolapse requiring surgical intervention, is based on international studies and guidelines. (7, 13, 17) Fisher's exact test, if the chi square assumptions were not met.
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RESULTS
One hundred and forty seven (147) patients were referred for mitral valve repair in the study period, of which 33 were not accepted for repair by the local heart team. One hundred and
fourteen (114) Of those accepted for surgery, 66 patients (57.9%) were males, 48 patients (42.1%) were females, and they had a mean age of 47.7 years; 57% of patients were of mixed ancestry, 22.8%
were African, 19.3% white, and 0.9% were undetermined.
Seventy five patients (65.8%) originated from rural areas, and 39 patients (34.2%) from urban areas.
Cardiovascular risk factors and past medical history ( 
Etiology of mitral valve disease
The predominant etiology was mitral valve prolapse with flail segment due to chord rupture (29%) (Figure 4 ).
Pre-operative transthoracic and transoesophageal echocardiogram parameters
The echocardiographic parameters used in the study are illustrated in Table 2 .
The estimated systolic pulmonary pressure was normal in 44 The underlying etiology of MR in the moderate degree group was congenital heart disease (6), ischaemic MR (5), infective endocarditis with large vegetation on MV (3), and post traumatic (1) ( Table 3 ). The primary indication for surgery in these patients was not the mitral regurgitation. The repair of the mitral valve in these cases was done at the time of surgery for the primary indication, according to current guidelines. (17) There were 38 patients (33.3%) with posterior leaflet involvement, 37 (32.5%) with anterior leaflet involvement, and 25 patients (21.9%) with bileaflet involvement. With regard to segment involvement, P2 was the most common segment involved (36%) (Figures 5 and 8) .
Comparison of the pre-operative echocardiographic parameters with the immediate and 6 month postoperative fi ndings 
Class III 6%
Class II 32% Class I 60%
Class IV 2% FIGURE 3: Post-operative NYHA functional class at 6 months.
FIGURE 2: Pre-operative NYHA functional class.
Class III 56%
Class II 30%
Class I 7%
Class IV 7% FIGURE 4: Etiology of mitral valve disease. There was no difference in median time between those who failed and those who had a successful repair.
Post-operative MR
The majority of patients had trace/mild mitral regurgitation at 6 months post-surgery. Only 2 patients had severe MR at 6 months after complicated repairs for infective endocarditis and a submitral aneurysm respectively. Both had redo surgery, with subsequent mitral valve replacement (Table 3) . 
Type of surgical repair

DISCUSSION
Mitral valve repair is associated with an operative mortality of approximately 3%, depending on the population and the pre-operative risk of patients undergoing surgery. (14, 15) Interna- MITRAL VALVE REPAIR SURGERY tionally published figures for peri-operative mortality are less than 2% for degenerative mitral regurgitation, with a freedom from mitral valve reoperation of 94% at 10 years. (7) In our series, the mortality rate for MVP was 4.8% at 30 days and 6 months -which is higher than the published data. The mortality rate at 30 days and 6 months post-operative for all repairs irrespective of etiology was 4.7% and 6.6% respec-tively, with ischaemic MR as the main cause of increased mortality.
Ischaemic MR is well known to have a significantly higher operative mortality than MVP. To our surprise, other etiologies included in this cohort -i.e. infective endocarditis and submitral aneurysms -were not associated with a significant increase in mortality. This might be due to selection bias, with patients with more advanced involvement not accepted/ considered for mitral valve repair. In our cohort, the 6 month mortality rate of patients undergoing surgery for ischaemic MR was higher than reported mortality rates (23% vs. 10%).
Given the limited number of patients undergoing surgery for ischaemic MR in our cohort, no clear conclusion can however be drawn from this. Freedom from reoperation was 98% at 6 months, which is similar to the published literature. (7, 13) Surprisingly, there was no association between functional class and survival in our cohort.
There was a significant improvement in symptoms at 6 months post-operative. NYHA functional class improved dramatically, most patients were asymptomatic (60%), and only a few had significant symptoms at 6 months (8%). The etiology in this group was mitral valve prolapse due to flail segment ( 
STUDY LIMITATIONS
This is a small cohort of patients undergoing mitral valve repair -in particular only a small number of patients underwent surgery for secondary (ischaemic) MR. The high mortality rate in this group should be interpreted with caution.
Conclusions drawn from retrospective analyses such as this should be made with caution, as it is often very difficult to control for all forms of bias. In this regard, one particular shortcoming in the echocardiographic analysis is the large cohort of patients for which a 6-month echocardiogram is not available. Most of these patients (26 of 28) were clinically evaluated at 6 months post-surgery, and no echocardiogram was requested -presumably due to the combination of a good immediate post-operative result on echocardiogram and good symptomatic status at follow up. Information on the exact circumstance related to the events leading up to the patients who died was not available, making it difficult to draw conclusions regarding cause of death.
CONCLUSION
Mitral valve prolapse was the predominant etiology in patients referred for mitral valve repair. The mortality rate for mitral valve repair in the prolapse group was 4.8% at 6 months.
Chordal insertion with annuloplasty was the most common intervention used. Bileaflet involvement was found to be an independent risk factor for repair failure. The mortality rate for all patients accepted for mitral valve repair was 6.6% at 6 months.
